LABMASTER LUCIA | Labmaster Lucia - revolutionizing blood diagnostics with rapid accurate low-cost point-of-care tests

Summary
The Labmaster Lucia is the next generation diagnostics instrument for point-of-care blood tests. The compact device harnesses the breakthrough Cathodic ElectroChemiLuminescence (CECL) method to increase diagnostic speed and precision. Using the Lucia, medical staff can perform in vitro diagnostics (IVD) anywhere and get accurate results within five minutes at a fraction of the cost of existing methods.
Blood diagnostics are critical for patient treatment, but current options are slow and costly due to large IVD immobile equipment. IVD devices are hard to miniaturize due to the scientific problem of sample medium signal interference. Labmaster's patented CECL technology overcomes signal disturbance problems using hydrated hot electrons that bypass fluid media, enabling the creation of small, mobile IVD devices for fast on-site diagnostics.
Using CECL, Labmaster has created two products: (1) The Lucia, a 2kg POC IVD unit; (2) Test cartridges with antibodies to test a range of medical conditions.
The Lucia improves on current FI and AECL IVD methods which require large expensive laboratory equipment, or have limited testing ranges. The Lucia has a wider testing range and allows simultaneous tests on one cartridge. It will be priced 50% below the current segment leader. This will reduce public health spending, improve treatment and lessen antibiotic prescription.
The Lucia and cartridges will be sold to hospitals and clinics in Europe and Asia via medtech distributors. One Asian distributor is secured, six more will be targetted in this project.
Labmaster Oy was founded in Finland in 1985, has 17 expert staff, and already commercialized 16 diagnostic innovations. It aims to sell 23,000 Lucia instruments and 10M cartridges by 2023, generating €291M in revenue.
This project will prepare for the development of a new cartridge to test for a common condition, and prepare for commercialisation.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/807844
Start date: 01-02-2018
End date: 31-05-2018
Total budget - Public funding: 71 429,00 Euro - 50 000,00 Euro
Cordis data

Original description

The Labmaster Lucia is the next generation diagnostics instrument for point-of-care blood tests. The compact device harnesses the breakthrough Cathodic ElectroChemiLuminescence (CECL) method to increase diagnostic speed and precision. Using the Lucia, medical staff can perform in vitro diagnostics (IVD) anywhere and get accurate results within five minutes at a fraction of the cost of existing methods.
Blood diagnostics are critical for patient treatment, but current options are slow and costly due to large IVD immobile equipment. IVD devices are hard to miniaturize due to the scientific problem of sample medium signal interference. Labmaster's patented CECL technology overcomes signal disturbance problems using hydrated hot electrons that bypass fluid media, enabling the creation of small, mobile IVD devices for fast on-site diagnostics.
Using CECL, Labmaster has created two products: (1) The Lucia, a 2kg POC IVD unit; (2) Test cartridges with antibodies to test a range of medical conditions.
The Lucia improves on current FI and AECL IVD methods which require large expensive laboratory equipment, or have limited testing ranges. The Lucia has a wider testing range and allows simultaneous tests on one cartridge. It will be priced 50% below the current segment leader. This will reduce public health spending, improve treatment and lessen antibiotic prescription.
The Lucia and cartridges will be sold to hospitals and clinics in Europe and Asia via medtech distributors. One Asian distributor is secured, six more will be targetted in this project.
Labmaster Oy was founded in Finland in 1985, has 17 expert staff, and already commercialized 16 diagnostic innovations. It aims to sell 23,000 Lucia instruments and 10M cartridges by 2023, generating €291M in revenue.
This project will prepare for the development of a new cartridge to test for a common condition, and prepare for commercialisation.

Status

CLOSED

Call topic

SMEInst-06-2016-2017

Update Date

27-10-2022
Images
No images available.
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
Horizon 2020
H2020-EU.2. INDUSTRIAL LEADERSHIP
H2020-EU.2.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies
H2020-EU.2.1.1. INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT)
H2020-EU.2.1.1.0. INDUSTRIAL LEADERSHIP - ICT - Cross-cutting calls
H2020-SMEINST-1-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-SMEINST-2-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-EU.2.3. INDUSTRIAL LEADERSHIP - Innovation In SMEs
H2020-EU.2.3.1. Mainstreaming SME support, especially through a dedicated instrument
H2020-SMEINST-1-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-SMEINST-2-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-EU.3. SOCIETAL CHALLENGES
H2020-EU.3.1. SOCIETAL CHALLENGES - Health, demographic change and well-being
H2020-EU.3.1.4. Active ageing and self-management of health
H2020-EU.3.1.4.0. Cross-cutting call topics
H2020-SMEINST-1-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-SMEINST-2-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-EU.3.1.6. Health care provision and integrated care
H2020-EU.3.1.6.0. Cross-cutting call topics
H2020-SMEINST-1-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well
H2020-SMEINST-2-2016-2017
SMEInst-06-2016-2017 Accelerating market introduction of ICT solutions for Health, Well-Being and Ageing Well